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Water Doesn’t Run Uphill (by Itself)*
Nelson B. Schiller, MD,† Xiushui Ren, MD‡
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vPulmonary artery (PA) pressure, raised in excess of
normal levels, is commonly encountered when per-
forming hemodynamic evaluation in left ventricular
(LV) diseases. The incidence of adverse outcomes is
proportional to the presence and severity of pulmo-
nary pressure elevation (1,2), making the recogni-
tion and understanding of mechanisms contributing
to this type of so-called “pulmonary hypertension”
particularly important. Logically, if the chambers
receiving transpulmonic flow (left atrium and ven-
tricle) have elevated mean pressures, in order to
maintain forward flow, the pressure at which flow is
See page 946
delivered to those chambers (mean PA pressure)
must also rise. The details of this process are,
however, more complex because of the many factors
governing these relationships. For example, LV
relaxation may be impaired to varying degrees,
pre-load and afterload can change quickly, atrial
function (reservoir, conduit, and contractility) may
be impaired or augmented, and pulmonary vascular
resistance may markedly modulate pulmonary pres-
sure. Thus, what might seem a simple relationship
between a diseased LV and elevated pulmonary
pressure is both complex and not adequately under-
stood.
Using the echocardiography databases of the
Mayo Clinic to investigate this problem, Miller et
al. (3) sought to define the role of LV diastolic
dysfunction as a determinant of pulmonary hyper-
tension (defined as a PA systolic pressure 45 mm
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ight atria [RA] gradient derived by the Bernoulli
quation from peak tricuspid regurgitation velocity
nd estimated RA pressure) in patients with LV
ystolic dysfunction (defined as LV ejection fraction
EF]40%) with or without functional mitral valve
egurgitation (quantitated by effective regurgitant
rifice area).
Among 5,516 patients screened 1,541 were in-
luded. Exclusion criteria were those known to
ndependently lead to elevated pulmonary pressure
nd included atrial fibrillation, organic valve dis-
ase, prosthetic valves, hypertrophic cardiomyopa-
hy, infiltrative myocardial disease, pericardial dis-
ase, recent myocardial infarction, lung disease,
ongenital heart disease, tachycardia, and primary
ulmonary hypertension.
Among these 1,541 subjects with an EF 40%,
33 (approximately one-third) met the pre-defined
evel of elevated PA pressure of 45 mm Hg.
ndexes of abnormal “diastolic function” (referred to
ereafter as elevated LV filling pressure) studied
ere transmitral flow velocity (E)/mitral annular
iastolic velocity (e=) and mitral deceleration time.
n this population, 772 (50%) of the study subjects
ad an E/e= ratio 15 and in those, 414 (78%) had
levated pulmonary pressure. A shortened mitral
eceleration time was also more common (65%)
mong those with elevated pulmonary pressure than
mong those without. The amount of mitral regur-
itation also tended to be greater in those with
levated pulmonary pressure but the association was
eaker.
By logistic regression, the severity of the EF
eduction did not independently predict elevated
ulmonary pressure, whereas age, abnormal dia-
tolic parameters, mitral regurgitation, and other
linical variables did provide incremental prognostic
alue. For example, an individual from the study
opulation had the greatest probability of elevated
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956pulmonary pressure if older and with functional
mitral regurgitation, abnormal diastolic function,
elevated serum creatinine, and a large left atrium. In
this example, the area under the receiver-operator
characteristic curve was 0.83.
Since the predictors examined in this study are
epiphenomena that increase LV filling pressure,
pulmonary pressure can be inferred to rise as a
mechanism of maintaining forward flow. In other
words, when water flows uphill there is a reason;
what that reason might be, is another story.
This study (3) is an interesting beginning as an
approach to this question because it clearly points to
a strong association between elevated LV diastolic
pressure and elevated pulmonary pressure. How-
ever, the offered interpretations of these data are,
perhaps, overreaching.
First, referring to echocardiographic measure-
ments that are most closely associated with elevated
filling pressure as indexes of “diastolic function” are
a common but problematic practice. Diastolic func-
tion (or lusitropy) is exceedingly complex (4) and
annot be adequately represented by a few veloci-
ies, volumes, or ratios. Since E/e= ratio (especially
15) and mitral deceleration time (especially 150
ms) have strong established correlations with ele-
vated filling pressure, these variables should be
referred to as markers of such pressure and not as
“diastolic function.” This change in terminology
does not detract from the findings of the study but
rather clarifies the mechanism through which ele-
vation in pulmonary pressure occurs.
Second, the term “pulmonary hypertension” is
probably a poor choice as a term describing the
Doppler findings in these patients and should be
limited to situations where there is confirmatory
evidence that mean pulmonary pressure is at least
25 mm Hg, and/or pulmonary vascular resistance
(PVR) is elevated. As discussed below, accurate
surrogates for these values are obtainable from
routine echocardiography. It is proposed that ele-
vated or raised pulmonary pressure be used as a term
where only peak systolic pressure is reported.
A complete discussion of a comprehensive ap-
proach to the study of right heart hemodynamics is
beyond the scope of an Editorial Comment and
readers are referred to a statement by the American
Society of Echocardiography on this subject (5).
However, a brief review of the available measure-
ments that should be considered in future studies is
offered both for the clinical value of such a listing
and their research potential. cRA pressure. The references cited in the methods
section for determining RA pressure describe 2
approaches that are at considerable (and critical)
variance in regard to methodology (6,7). In the first
method, an arbitrary value of 14 mm Hg for RA
pressure is added to the tricuspid regurgitation
(TR) jet and in the second method, the inferior
vena cava is used with normal RA pressure consid-
ered 6 mm Hg. Since both of these studies are
from the institution performing the current study,
clinical echocardiography readers within the insti-
tution may have introduced considerable inconsis-
tency into the reported values of pulmonary pres-
sure through favoring one or the other method. For
example, if an arbitrary and, in our opinion, unac-
ceptably high value of 14 mm Hg is added, subjects
with a RV/RA gradient of 31 mm Hg will meet
study criteria for pulmonary hypertension. Since
mean RA pressures 5 mm Hg are common, the
possibility of misclassifications of sufficient magni-
tude to substantially alter these data cannot be
dismissed. We eschew arbitrary RA pressure values
and recommend always using inferior vena cava
size, collapsibility, and hepatic vein Doppler flow
patterns as the primary means of judging RA
pressure (8–10).
Peak systolic PA pressure (RV/RA gradient in
absence of pulmonary stenosis) from peak TR
velocity has become the favorite straw man of critics
of Doppler hemodynamics (11). The peak TR jet is
a second order function of velocity and, as such, this
expression of pressure varies considerably with
slight variations of the placement of an electronic
cursor on a wave form edge that is often less than
distinct. Because of these shortcomings, it is not
desirable as a stand-alone measurement.
Peak mean and mean pulmonary pressure. There are
number of ways to derive this family of values.
irst, the area under the TR jet when solved as a
ean pressure and added to RA pressure yields
eak mean PA pressure. Peak mean PA pressure
grees closely with catheter derived mean pressure
nd is far less vulnerable to the vagaries of the peak
R jet (12). This value can also be derived by the
ernoulli equation from the opening pulmonic
egurgitation velocity added to RA pressure and
rom the end diastolic pulmonary regurgitation in
ombination with peak TR velocity using the for-
ula for mean pressure (systole 2 diastole)/3.
sing Peak mean PA as an expression of pulmonary
ressure as a primary variable is recommended both
linically and in research.
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957Pulmonary vascular resistance analogue. A simple
atio of peak TR velocity/pulmonary velocity time
ntegral has been shown to correlate with catheter-
erived PVR (13,14). This method has been used to
void erroneous impressions of pulmonary hyper-
ension resulting from raised pulmonary pressure in
he setting of high cardiac output of end-stage
epatic failure (15).
In summary, echocardiography is a powerful toolEuropean Association of Echocardi-
ography, a registered branch of the
1
1
al. Accuracy of Do
raphy in the hemodlied to the problem of elevated pulmonary pres-
ure, a comprehensive prospective approach using
hese proposed tools will widen our understanding
f the conditions and mechanisms that assure that
ater runs uphill when it must.
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